エクスプレス:臨床試験におけるプラセボ反応の理解と対処:包括的なガイド
Krishna S Upadhye1, Paritosh Tayade2
1Pune, MH, India.
まとめ
このレビューは,臨床試験におけるプラセボ反応メカニズムを明確にし,その影響を軽減するための戦略を提供しています. これらの効果を理解することは,信頼できる倫理的な研究成果に不可欠です.
科学分野:
- 臨床研究方法論 臨床研究方法論
- 心理神経免疫学 心理神経免疫学について
- 医療倫理 医療倫理について
背景:
- プラセボ反応は,様々な治療分野における臨床試験の解釈を大幅に複雑にする.
- プラセボ効果の多面的性質を理解することは,試験の有効性と信頼性の高い結果評価を確保するために不可欠です.
研究 の 目的:
- プラセボ反応を誘発する心理的,神経生物学的,社会文化的メカニズムを解明する.
- 臨床試験の有効性に対するプラセボ効果の影響を評価し,倫理的な緩和戦略を探求する.
- 臨床研究の質と倫理的整合性を向上させるための実践的な指針を提供すること.
主な方法:
- プラセボ反応の心理的および神経生物学的な要因に関する包括的な文献レビュー.
- 臨床試験の設計と方法論的アプローチの分析 (例えば,プラセボランイン,参加者選択,統計モデリング).
- プラセボ効果に関連する規制,倫理的検討,ケーススタディの検討.
主要な成果:
- プラセボ反応は,心理的条件付け,神経生物学的経路,社会文化的要因,患者と臨床医のダイナミクスを含む複雑な相互作用によって形成されます.
- プラセボランイン期間を最適化し,慎重に参加者を選択するなどの方法論的戦略は,プラセボ効果を特定し管理するのに役立ちます.
- 倫理的な考慮は,プラセボ現象に対処する際の科学的厳密さと参加者の福祉のバランスを必要とします.
結論:
- プラセボ反応の効果的な管理には,科学的な妥当性を参加者中心のケアと統合した,個別化された戦略が必要です.
- このレビューは,臨床試験の信頼性と倫理基準を高めるために,利害関係者にとって実用的なリソースを提供します.
- プラセボ効果に積極的に取り組むことは,信頼性の高い臨床研究と治療の開発を進めるために不可欠です.
さらに関連する動画
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
11.3K
11:51Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making
Published on: March 2, 2011
15.7K
関連する概念動画
The Placebo Effect
6.9K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.9K
Blinding
4.0K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
4.0K
Blind Procedures
13.7K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
13.7K
Clinical Trials
10.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.9K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
488
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
488
Clinical Trials: Overview
5.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K
